Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

5.1%

6 terminated/withdrawn out of 117 trials

Success Rate

93.5%

+7.0% vs industry average

Late-Stage Pipeline

9%

10 trials in Phase 3/4

Results Transparency

43%

37 of 87 completed trials have results

Key Signals

12 recruiting37 with results

Enrollment Performance

Analytics

Phase 1
54(49.5%)
N/A
22(20.2%)
Phase 2
21(19.3%)
Phase 4
7(6.4%)
Phase 3
3(2.8%)
Early Phase 1
2(1.8%)
109Total
Phase 1(54)
N/A(22)
Phase 2(21)
Phase 4(7)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (117)

Showing 20 of 117 trials
NCT03882073Not ApplicableRecruiting

A Novel Approach to Upper Extremity Amputation to Augment Volitional Control and Restore Proprioception

Role: collaborator

NCT07467707Phase 3Recruiting

An Efficacy, Safety, and Immunogenicity Study of CHIKV VLP Vaccine for the Prevention of Chikungunya Disease in Adolescents and Adults

Role: collaborator

NCT07654777Not ApplicableRecruiting

The Efficacy of Vitamin D Supplementation to Sustain Performance Outcomes

Role: lead

NCT06982183Phase 4Recruiting

The Effects of Propranolol and Hydrocortisone on Military-Relevant Performance Outcomes

Role: lead

NCT07533136Not ApplicableNot Yet Recruiting

Tafenoquine Combinations for Improved Radical Cure Efficacy of Plasmodium Vivax

Role: lead

NCT06943404Phase 2Recruiting

BXCL501 After Stress to Increase Recovery Success

Role: collaborator

NCT07286955Not ApplicableRecruiting

Life Skills Training for Soldiers Arriving at Their First Duty Location

Role: collaborator

NCT05543993Completed

COVID Booster in Pregnancy and Lactation

Role: collaborator

NCT06205056Phase 1Recruiting

Evaluation of Safety and Immunogenicity of Ad26.Mos4.HIV and CH505 TF chTrimer Combination in Healthy Adults

Role: collaborator

NCT04301154Phase 1Completed

Safety and Effects of Using Prime-boost HIVIS DNA and MVA-CMDR Vaccine Regimens With or Without Toll-like Receptor 4 Agonist on HIV Reservoirs in Perinatally HIV Infected Children and Youth

Role: collaborator

NCT04784767Phase 1Completed

PHASE 1 SARS-COV-2-Spike-Ferritin-Nanoparticle (SpFN) Vaccine With ALFQ Adjuvant for Prevention of COVID-19

Role: collaborator

NCT02945501Not ApplicableRecruiting

Transcranial Electrical Stimulation (TES) at Slow Oscillation (SO) Frequency During NREM Sleep

Role: collaborator

NCT06824350Not ApplicableRecruiting

Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates

Role: collaborator

NCT04273841Not ApplicableTerminated

Impact of Sleep Deprivation and Caffeine in Medical Professionals

Role: lead

NCT05547880Completed

CNS Correlates of Extended Sleep Restriction

Role: lead

NCT04505501Phase 2Active Not Recruiting

Reducing HIV Persistence in Lymph Nodes by Interleukin-15 (IL-15) Receptor Super-agonist (N-803) in Acute HIV Infection

Role: collaborator

NCT04273776Early Phase 1Active Not Recruiting

A Comparison of the Physiological and Behavioral Effects of Suvorexant and Zolpidem in Healthy Volunteers: A Randomized, Double-blind, Placebo Controlled Study

Role: lead

NCT04474015Not ApplicableEnrolling By Invitation

Optimizing Volunteer Comfort for Transcranial Electrical Stimulation (TES): An Assessment

Role: collaborator

NCT04826094Phase 1Completed

A Study to Assess the Safety and Immune Response to Env-C DNA and Protein Vaccines in Kenya

Role: collaborator

NCT05959616Phase 1Recruiting

Shigella Sonnei 53G Human Infection Study in Kenyan Adults

Role: collaborator